These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 24875445

  • 1. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
    Lorendeau D, Dury L, Genoux-Bastide E, Lecerf-Schmidt F, Simões-Pires C, Carrupt PA, Terreux R, Magnard S, Di Pietro A, Boumendjel A, Baubichon-Cortay H.
    Biochem Pharmacol; 2014 Aug 01; 90(3):235-45. PubMed ID: 24875445
    [Abstract] [Full Text] [Related]

  • 2. Flavonoid dimers are highly potent killers of multidrug resistant cancer cells overexpressing MRP1.
    Dury L, Nasr R, Lorendeau D, Comsa E, Wong I, Zhu X, Chan KF, Chan TH, Chow L, Falson P, Di Pietro A, Baubichon-Cortay H.
    Biochem Pharmacol; 2017 Jan 15; 124():10-18. PubMed ID: 27984000
    [Abstract] [Full Text] [Related]

  • 3. Ferrocene-embedded flavonoids targeting the Achilles heel of multidrug-resistant cancer cells through collateral sensitivity.
    Pérès B, Nasr R, Zarioh M, Lecerf-Schmidt F, Di Pietro A, Baubichon-Cortay H, Boumendjel A.
    Eur J Med Chem; 2017 Apr 21; 130():346-353. PubMed ID: 28273561
    [Abstract] [Full Text] [Related]

  • 4. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
    van Zanden JJ, Geraets L, Wortelboer HM, van Bladeren PJ, Rietjens IM, Cnubben NH.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1607-17. PubMed ID: 15041478
    [Abstract] [Full Text] [Related]

  • 5. Identification of xanthones as selective killers of cancer cells overexpressing the ABC transporter MRP1.
    Genoux-Bastide E, Lorendeau D, Nicolle E, Yahiaoui S, Magnard S, Di Pietro A, Baubichon-Cortay H, Boumendjel A.
    ChemMedChem; 2011 Aug 01; 6(8):1478-84. PubMed ID: 21634011
    [Abstract] [Full Text] [Related]

  • 6. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids.
    Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, Cole SP.
    Mol Pharmacol; 2001 May 01; 59(5):1171-80. PubMed ID: 11306701
    [Abstract] [Full Text] [Related]

  • 7. MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion.
    Lorendeau D, Dury L, Nasr R, Boumendjel A, Teodori E, Gutschow M, Falson P, Di Pietro A, Baubichon-Cortay H.
    Curr Med Chem; 2017 May 01; 24(12):1186-1213. PubMed ID: 27855620
    [Abstract] [Full Text] [Related]

  • 8. Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1.
    Barattin R, Perrotton T, Trompier D, Lorendeau D, Di Pietro A, d'Hardemare Adu M, Baubichon-Cortay H.
    Bioorg Med Chem; 2010 Sep 01; 18(17):6265-74. PubMed ID: 20691599
    [Abstract] [Full Text] [Related]

  • 9. Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1).
    Schmitt SM, Stefan K, Wiese M.
    Biochim Biophys Acta Biomembr; 2017 Jan 01; 1859(1):69-79. PubMed ID: 27810353
    [Abstract] [Full Text] [Related]

  • 10. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S, Khonkarn R, Moreno A, Baubichon-Cortay H, Miri R, Khoshneviszadeh M, Saso L, Edraki N, Falson P, Firuzi O.
    Toxicol Appl Pharmacol; 2019 Jan 01; 362():136-149. PubMed ID: 30391378
    [Abstract] [Full Text] [Related]

  • 11. MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells.
    Gana CC, Hanssen KM, Yu DMT, Flemming CL, Wheatley MS, Conseil G, Cole SPC, Norris MD, Haber M, Fletcher JI.
    Biochem Pharmacol; 2019 Oct 01; 168():237-248. PubMed ID: 31302132
    [Abstract] [Full Text] [Related]

  • 12. Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1.
    Trompier D, Chang XB, Barattin R, du Moulinet D'Hardemare A, Di Pietro A, Baubichon-Cortay H.
    Cancer Res; 2004 Jul 15; 64(14):4950-6. PubMed ID: 15256468
    [Abstract] [Full Text] [Related]

  • 13. 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity.
    Rocha Gda G, Oliveira RR, Kaplan MA, Gattass CR.
    Eur J Pharmacol; 2014 Oct 15; 741():140-9. PubMed ID: 25111243
    [Abstract] [Full Text] [Related]

  • 14. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
    de Jong MC, Scheffer GL, Broxterman HJ, Hooijberg JH, Slootstra JW, Meloen RH, Kreitman RJ, Husain SR, Joshi BH, Puri RK, Scheper RJ.
    Clin Cancer Res; 2003 Oct 15; 9(13):5009-17. PubMed ID: 14581376
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
    Wang H, Li X, Chen T, Wang W, Liu Q, Li H, Yi J, Wang J.
    Oncol Rep; 2013 Feb 15; 29(2):676-84. PubMed ID: 23229154
    [Abstract] [Full Text] [Related]

  • 16. Effects of new 4-aryl-1,4-dihydropyridines and 4-arylpyridines on drug efflux mediated by multidrug resistance-associated protein 1.
    Zhou XF, Coburn RA, Morris ME.
    J Pharm Sci; 2005 Oct 15; 94(10):2256-65. PubMed ID: 16136554
    [Abstract] [Full Text] [Related]

  • 17. High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1).
    Peterson BG, Tan KW, Osa-Andrews B, Iram SH.
    Pharmacol Res; 2017 May 15; 119():313-326. PubMed ID: 28258008
    [Abstract] [Full Text] [Related]

  • 18. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.
    Sampson A, Peterson BG, Tan KW, Iram SH.
    Biomed Pharmacother; 2019 Oct 15; 118():109289. PubMed ID: 31401398
    [Abstract] [Full Text] [Related]

  • 19. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
    Ascione A, Cianfriglia M, Dupuis ML, Mallano A, Sau A, Pellizzari Tregno F, Pezzola S, Caccuri AM.
    Cancer Chemother Pharmacol; 2009 Jul 15; 64(2):419-24. PubMed ID: 19288261
    [Abstract] [Full Text] [Related]

  • 20. Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells.
    Tan KW, Sampson A, Osa-Andrews B, Iram SH.
    Drug Metab Dispos; 2018 Dec 15; 46(12):1856-1866. PubMed ID: 30232176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.